Related Experiment Videos
Tazarotene in combination with topical corticosteroids
1Department of Dermatology, Mount Sinai Medical Center, New York, New York, USA.
Journal of the American Academy of Dermatology
|October 20, 1998
Summary
Combining topical corticosteroids with tazarotene offers enhanced efficacy and tolerability for dermatological conditions. This combination therapy provides faster results and reduces the likelihood of relapse compared to tazarotene alone.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Topical corticosteroids and tazarotene have distinct mechanisms of action.
- Combination therapy may yield additive or synergistic therapeutic effects.
- Corticosteroids can mitigate initial adverse effects like erythema, while tazarotene may offer sustained benefits and prevent relapse.
Purpose of the Study:
- To evaluate the efficacy and tolerability of combining topical corticosteroids with tazarotene.
- To compare combination therapy against tazarotene monotherapy and placebo.
Main Methods:
- A large, controlled clinical trial was conducted.
- Participants received tazarotene therapy combined with medium- or high-potency corticosteroids.
- A placebo cream was used as a comparator for tazarotene monotherapy.
Main Results:
- Tazarotene plus medium- or high-potency corticosteroids demonstrated greater and more rapid efficacy.
- The combination therapy showed superior tolerability compared to tazarotene plus placebo.
- Adverse effects such as erythema were potentially minimized by the corticosteroid component.
Conclusions:
- Combination therapy with topical corticosteroids and tazarotene is effective and well-tolerated.
- This approach offers improved treatment outcomes for dermatological conditions.
- The combination may enhance initial response and long-term therapeutic effects.